We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$206B
AUM Growth
$0
Cap. Flow
-$1.88B
Cap. Flow %
-0.91%
Top 10 Hldgs %
22.01%
Holding
2,677
New
Increased
3
Reduced
5
Closed

Top Buys

Rank Stock Value
1
GTE icon
Gran Tierra Energy
GTE
+$4.88M
2
LOGC
ContextLogic
LOGC
+$1.93M
3
TRI icon
Thomson Reuters
TRI
+$61.5K

Top Sells

Rank Stock Value
1
CHDN icon
Churchill Downs
CHDN
+$12M
2
CXT icon
Crane NXT
CXT
+$8.18M
3
MDU icon
MDU Resources
MDU
+$3.62M
4
AGEN
Agenus
AGEN
+$13.8K
5
DOUG icon
Douglas Elliman
DOUG
+$8.55K

Sector Composition

Rank Sector Weight
1 Technology 28.09%
2 Healthcare 14.47%
3 Financials 11.11%
4 Consumer Discretionary 10.49%
5 Industrials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLAR icon
2551
Clarus
CLAR
$143M
$130K ﹤0.01%
13,754
NGM
2552
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$128K ﹤0.01%
31,431
EVLV icon
2553
Evolv Technologies
EVLV
$1.1B
$128K ﹤0.01%
40,900
SES icon
2554
SES AI
SES
$208M
$128K ﹤0.01%
43,234
CDXS icon
2555
Codexis
CDXS
$158M
$126K ﹤0.01%
30,386
INO icon
2556
Inovio Pharmaceuticals
INO
$69M
$124K ﹤0.01%
12,610
SANA icon
2557
Sana Biotechnology
SANA
$980M
$124K ﹤0.01%
37,818
CCCC icon
2558
C4 Therapeutics
CCCC
$412M
$123K ﹤0.01%
39,287
CSAN icon
2559
Cosan
CSAN
$2.84B
$123K ﹤0.01%
10,408
IVR icon
2560
Invesco Mortgage Capital
IVR
$805M
$122K ﹤0.01%
11,029
RAD
2561
DELISTED
Rite Aid Corporation
RAD
$121K ﹤0.01%
54,060
PSTX
2562
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$120K ﹤0.01%
39,000
CLOV icon
2563
Clover Health Investments
CLOV
$2.51B
$120K ﹤0.01%
141,869
TSP
2564
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$118K ﹤0.01%
80,385
AMRX icon
2565
Amneal Pharmaceuticals
AMRX
$5.79B
$118K ﹤0.01%
84,912
FUBO icon
2566
FuboTV Inc
FUBO
$273M
$117K ﹤0.01%
8,073
ATAI icon
2567
AtaiBeckley Inc
ATAI
$2.68B
$114K ﹤0.01%
63,211
KNSA icon
2568
Kiniksa Pharmaceuticals
KNSA
$5.93B
$114K ﹤0.01%
10,608
PGEN icon
2569
Precigen
PGEN
$2.59B
$113K ﹤0.01%
107,073
LOGC
2570
DELISTED
ContextLogic
LOGC
$113K ﹤0.01%
252,438
+244,023
+2,900% +$1.93M
ONTF
2571
DELISTED
ON24
ONTF
$112K ﹤0.01%
12,777
TLS icon
2572
Telos
TLS
$358M
$112K ﹤0.01%
44,084
SI
2573
DELISTED
Silvergate Capital Corporation
SI
$110K ﹤0.01%
67,732
BIRD icon
2574
Smartbird Inc
BIRD
$22.3M
$107K ﹤0.01%
4,462
GTHX
2575
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$106K ﹤0.01%
39,600

Similar funds

UBS AM's Q2 2023 Portfolio in Review

As of Q2 2023, UBS AM held 2,677 positions worth $206B, unchanged from the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. UBS AM opened no new positions and made no exits, leaving the 2,677-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, unchanged from a quarter earlier, followed by Healthcare and Financials.

  • UBS AM added most to Gran Tierra Energy in Q2 2023, an estimated $4.88M increase.
  • UBS AM's biggest Q2 2023 reduction was Churchill Downs, cutting an estimated $12M.
  • UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q2 2023.
  • UBS AM opened 0 new positions and closed 0 in Q2 2023.
  • UBS AM's portfolio value was unchanged quarter-over-quarter at $206B.

Based on UBS AM's 13F filing for Q2 2023, filed 11 Aug 2023.